TFAP2B Antibody

Code CSB-PA784528
Size US$166
Order now
Image
  • Gel: 10%SDS-PAGE, Lysate: 40 μg, Lane: Jurkat cells, Primary antibody: CSB-PA784528(TFAP2B Antibody) at dilution 1/416.6, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 40 seconds
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Uniprot No.
Target Names
TFAP2B
Alternative Names
Activating enhancer binding protein 2 beta antibody; Activating enhancer-binding protein 2-beta antibody; AP 2B antibody; AP2 B antibody; AP2-beta antibody; AP2B antibody; AP2B_HUMAN antibody; AP2beta antibody; MGC21381 antibody; OTTHUMP00000039925 antibody; PDA2 antibody; TFAP 2B antibody; Tfap2b antibody; Transcription factor AP 2 beta antibody; Transcription factor AP-2-beta antibody; Transcription factor AP2 beta antibody
Raised in
Rabbit
Species Reactivity
Human,Mouse
Immunogen
Synthetic peptide of Human TFAP2B
Immunogen Species
Homo sapiens (Human)
Conjugate
Non-conjugated
Isotype
IgG
Purification Method
Antigen affinity purification
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
-20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol
Form
Liquid
Tested Applications
ELISA,WB
Recommended Dilution
Application Recommended Dilution
ELISA 1:1000-1:2000
WB 1:200-1:1000
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Sequence-specific DNA-binding protein that interacts with inducible viral and cellular enhancer elements to regulate transcription of selected genes. AP-2 factors bind to the consensus sequence 5'-GCCNNNGGC-3' and activate genes involved in a large spectrum of important biological functions including proper eye, face, body wall, limb and neural tube development. They also suppress a number of genes including MCAM/MUC18, C/EBP alpha and MYC. AP-2-beta appears to be required for normal face and limb development and for proper terminal differentiation and function of renal tubular epithelia.
Gene References into Functions
  1. Data suggest that expression of TFAP2B in lobular carcinoma in situ and invasive lobular breast cancer is up-regulated as compared to control mammary gland epithelium; TFAP2B appear to be involved in regulation of cell proliferation in these slow-growing breast cancer subtypes. PMID: 29035379
  2. previously, only 10 different pathogenic variants in the TFAP2B gene have been associated with the Char syndrome and patent ductus arteriosus (human gene mutation database subscription). We have thus identified the 11th mutation, namely, c.851T>C, p. Leu284Ser, which cosegregates with the phenotype. PMID: 29683802
  3. study demonstrates that AP-2beta promotes tumor growth and predicts poor prognosis, and may represent a potential therapeutic target for breast cancer. PMID: 29972820
  4. Reduced TFAP2B expression in EC was significantly associated with high grade (OR=2.2 for well, moderate vs. poor), stage (OR=2.5 for I vs. IV), histology (OR=1.8 for serous vs. endometrioid), distant metastasis (OR=2.4 for positive vs. negative) (all p-values<0.05). PMID: 29602546
  5. TFAP2B mutation is associated with tooth abnormalities. PMID: 28381879
  6. AP-2 beta and beta-catenin interact both in vitro through GST pull-down assays and in vivo by co-immunoprecipitation. We further identified the interaction regions to the DNA-binding domain of AP-2 beta and the 1-9 Armadillo repeats of beta-catenin. PMID: 28277615
  7. Single nucleotide polymorphisms (SNP) in angiotensin II receptor, type 1 (AGTR1), transcription factor AP-2 beta (TFAP2B), and tumor necrosis factor receptor-associated factor 1 (TRAF1) have been reported to be associated with the incidence of PDA in preterm infants. PMID: 26615960
  8. results suggest that TFAP2B is playing a vital role in retaining retinoic acid responsiveness and mediating noradrenergic neuronal differentiation in neuroblastoma. PMID: 26598443
  9. The presence of the nine-repeat variant of the TFAP-2beta intron 1 VNTR appears to protect girls with ADHD symptoms from the co-expression of symptoms of depression. PMID: 23824473
  10. The expression of TFAP-2beta mRNA in tissue of patients with endometrial carcinoma was higher than that of normal endometrium. The expression of TFAP-2beta mRNA in endometrial tissue of patients with metabolism syndrome was higher than that of lean ones. PMID: 26189251
  11. TFAP2B overexpression contributes to tumor growth and a poor prognosis of human lung adenocarcinoma through modulation of ERK and VEGF/PEDF signaling. PMID: 24766673
  12. The AP-2beta polymorphism significantly influenced cognitive performance, whereas the MAOA and COMT polymorphisms did not. PMID: 23881096
  13. A haploinsufficiency effect of TFAP2B could be involved in familial isolated patent ductus arteriosus. PMID: 24507797
  14. TFAP2B rs987237 and dietary protein/carbohydrate interacted to modify weight maintenance. PMID: 24081236
  15. genomic GATA4 and TFAP2B missense mutations may be associated with nonfamilial congenital heart disease with diverse clinical phenotypes in patients with congenital heart disease from southern China PMID: 22959235
  16. Under energy restriction, TFAP2B may modify the effect of dietary fat intake on weight loss and waist reduction PMID: 22952648
  17. The findings suggest the lack of involvement of known mutations of TFAP2B with syndromic or nonsyndromic CHDs in Mysore patients PMID: 22199100
  18. TFAP2B mutation should be considered a risk factor for isolated PDA. However, the detailed genetic mechanism underlying nonsyndromic the PDA-causing TFAP2B mutation is yet to be elucidated. PMID: 21643846
  19. This study supports a role of the SLC6A4, DRD4 and TFAP2B genes in the temperament, including a gene-gene interaction between SLC6A4 and TFAP2B. It also provides evidence about an effect of the TFAP2B polymorphism in TFAP2B gene transcription. PMID: 21504541
  20. A novel splice-junction in TFAP-2B gene might lead to hereditary patent ductus arteriosus in a Chinese family. PMID: 21215182
  21. central obesity-associated variants in LYPLAL1, NRXN3, MSRA, and TFAP2B PMID: 21674055
  22. It causes accumulation of neutral fats and causes insulin resistance through exaggerated glucose uptake independent of insulin and induces abnormal adipokine secretion, fat cell enlargement and insulin resistance. PMID: 21766608
  23. Loss of TFAP2B is associated with retinoblastoma. PMID: 20607706
  24. TFAP2B seems to regulate the expression of various adipokines in vivo PMID: 20019683
  25. The present study identifies TFAP2b as a suggestive candidate gene in alcohol dependence. PMID: 19778525
  26. no association between a transcription factor Activating Protein 2beta (AP-2beta) gene variant and schizophrenia PMID: 12270648
  27. AP-2beta intron 2 genotype is associated with low levels of anxiety-related personality traits in women. PMID: 14673213
  28. No association between the AP-2beta genotype and measures of dopamine receptor density, or CSF 5-HIAA concentrations. PMID: 15057523
  29. AP-2beta expression was observed in the low-stage subtypes of renal cell carcinoma, and this transcription factor may be related to early carcinogenesis. PMID: 15245963
  30. No differences are observed in AP-2 beta genotype frequencies between 176 subjects with premenstrual dysphoric disorder (PMDD) and 91 healthy controls. PMID: 15722186
  31. Genetic variations in the gene encoding TFAP2B are associated with type 2 diabetes mellitus. PMID: 15940393
  32. TFAP2B may contribute to the pathogenesis of type 2 diabetes through regulation of adipocytokine gene expression, and that TFAP2B may be a promising target for treatment or prevention of this disease. PMID: 16373396
  33. Boys and girls with the combination of presence of the short 5-HTTLPR, and homozygosity for the long AP-2beta genotype scored significantly lower on Self-Transcendence and Spiritual Acceptance. PMID: 17123722
  34. Investigators speculate on the possible role of TFAP2B gene on the duplicated segment in the three reported cases of partial trisomy. PMID: 17185054
  35. TFAP2B was validated as direct target gene mediating the anti-apoptotic function of PAX3/FKHR PMID: 17525748
  36. L-PGDS gene expression in TE671 cells was activated by USF1 through the aE-box within intron 4 and cooperatively by AP-2beta in the promoter in a cell-type-specific manner. PMID: 17574780
  37. a potential usefulness of AP-2beta polymorphisms in explaining or predicting central nervous diseases, drug effects and side effects. PMID: 18358611
  38. Novel TFAP2B mutation in nonsyndromic patent ductus arteriosus is reported. PMID: 18752453
  39. Reduction of TFAP2B expression could have a protective effect against future risk of complications associated with decreased insulin sensitivity and central adiposity, such as type 2 diabetes and coronary heart disease. PMID: 19325541
  40. TFAP2B, LYPLAL1 and MSRA are associated with adiposity and fat distribution. PMID: 19557161
  41. AP-2beta directly inhibits adiponectin gene expression by displacing NF-YA and binding to its promoter. PMID: 16954217
  42. Novel TFAP2B mutations causing Char syndrome have a dominant-negative effect and provide a genotype-phenotype correlation. PMID: 11505339

Show More

Hide All

Involvement in disease
Char syndrome (CHAR); Patent ductus arteriosus 2 (PDA2)
Subcellular Location
Nucleus.
Protein Families
AP-2 family
Database Links

HGNC: 11743

OMIM: 169100

KEGG: hsa:7021

STRING: 9606.ENSP00000377265

UniGene: Hs.33102

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*